Deleterious germline CARD11 gain-of-function variants alter human B-cell and CD4+ T-cell differentiation and function
Clinical and Experimental Immunology · 06.01.2026 · 220 (1)
DOI: 10.1093/cei/uxag034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Immunology, online erschienen am 12.06.2026. Verfasst von Tina Nguyen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Garvan Institute of Medical Research, Darlinghurst, NSW, Australia. Hauptthemen laut MEDLINE: CARD Signaling Adaptor Proteins, Guanylate Cyclase, B-Lymphocytes, CD4-Positive T-Lymphocytes. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council of Australia, National Institute of Allergy and Infectious Diseases, NIH HHS.
Abstract (Originalsprache)
CARD11 is a scaffold protein expressed primarily in hematopoietic tissues, shaping key processes in B and T cells via regulation of Ag-linked signaling pathways, including NF-κB, mTOR, JNK, and AKT. Heterozygous, gain-of-function (GOF) variants in its encoding gene, CARD11, are implicated in a human disorder characterized by frequent upper respiratory infections, poor responses to polysaccharide vaccines, vulnerability to certain opportunistic viruses, and polyclonal B-cell expansion, likely predisposing these patients to lymphoma. Over the past decade, several studies have elucidated some of the B-cell functional defects that likely underlie the patients’ infectious phenotype. However, the potential contributions of CARD11 GOF variants to subpopulations of T cells have not been explored in detail. Therefore, our study sought to investigate the effect of increased CARD11 activity on the development, maturation, activation, differentiation, and effector function of adaptive lymphocytes from a cohort of five individuals harboring monoallelic CARD11 GOF variants through detailed ex vivo immunophenotyping and in vitro analyses. Our findings revealed intrinsic requirements for CARD11 in activation, differentiation, and effector function of human naïve B cells. Contrary to previous reports, intact CARD11 activity is also required for multiple aspects of CD4+ T-cell homeostasis alongside its notable role in the humoral immune response. Overall, these results shed light on mechanisms underlying disease pathogenesis due to not only CARD11 GOF variants but also LOF variants and reveal opportunities to consider targeted therapies in CARD11 GOF patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
- School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, Kensington, NSW,Australia.
- Department of Pharmacology & Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
- Department of Haematology, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.
- Awanui Labs, Dunedin, New Zealand.
- Human Immunological Diseases Section, Laboratory of Clinical Immunology and Microbiology, Intramural Research Program, NIAID, NIH, Bethesda, MD, USA.
ORCID-Profile: Andrew L Snow, Stuart G Tangye
Förderung
- National Health and Medical Research Council of Australia
- National Institute of Allergy and Infectious Diseases
- NIH HHS
- Australian Government Research Training Program Scholarship (RTP)
- National Institutes of Health
Zitieren
APA
Nguyen, T., Kallarakal, M. A., Ludgate, J. L., Morison, I. M., Su, H. C., Arjunaraja, S., Snow, A. L., Ma, C. S., & Tangye, S. G. (2026). Deleterious germline CARD11 gain-of-function variants alter human B-cell and CD4+ T-cell differentiation and function. Clinical and Experimental Immunology, 220(1). https://doi.org/10.1093/cei/uxag034
Vancouver
Nguyen T, Kallarakal MA, Ludgate JL, Morison IM, Su HC, Arjunaraja S, et al. Deleterious germline CARD11 gain-of-function variants alter human B-cell and CD4+ T-cell differentiation and function. Clinical and Experimental Immunology. 2026;220(1). doi:10.1093/cei/uxag034
BibTeX
@article{Nguyen2026,
author = {Nguyen, Tina and Kallarakal, Melissa A and Ludgate, Jackie L and Morison, Ian M and Su, Helen C and Arjunaraja, Swadinhya and Snow, Andrew L and Ma, Cindy S and Tangye, Stuart G},
title = {Deleterious germline CARD11 gain-of-function variants alter human B-cell and CD4+ T-cell differentiation and function},
journal = {Clinical and Experimental Immunology},
year = {2026},
volume = {220},
number = {1},
doi = {10.1093/cei/uxag034}
}
EUVIMED